World Allergy Congress News & Updates

July 05, 2011
Contact: Marechiel Santos-Lang
+1 414 276 1791

New Horizon Session – Asthma and Co-Morbid Conditions
Sunday, 4 December
13:00 – 16:30

Session 1

Overview of Co-Morbid Conditions
| Richard F. Lockey (United States)
Related publication: Prevalence of upper respiratory symptoms in patients with symptomatic gastroesophageal reflux disease.

| Marek L. Kowalski (Poland)
Related publication: T cell inflammatory response, Foxp3 and TNFRS18-L regulation of peripheral blood mononuclear cells from patients with nasal polyps-asthma after staphylococcal superantigen stimulation.

| Ruby Pawankar (Japan)
Related publication: Rhinosinusitis in children and asthma severity.


Session 2

Vitamin D, Obesity and Asthma
| Juan Carlos Celedon (United States)
Related publication: Decreased response to inhaled steroids in overweight and obese asthmatic children. 

Gastroesophageal Reflux Disease (GERD) or Laryngopharyngeal Reflux
| Dennis Ledford (United States)
Related publication: Primary gastrointestinal lymphangiectasia presenting as cryptococcal meningitis.

Vocal Cord Dysfunction
| Mario Zernotti (Argentina)
Related publication: Allergic rhinitis update and its impact on asthma (ARIA 2008). Latin American perspective.

New Horizon Sessions are the bookend sessions of the Congress. These sessions are designed to showcase the latest science in allergy, asthma and clinical immunology. The sessions will include premier presenters in the field. New Horizon Sessions are scheduled as either half-day or full-day sessions on 4 and 8 December.

If your company is interested in this New Horizon topic, please contact the WAO Secretariat ( to discuss partnership opportunities.

Click here to view a full list of Exhibition and Partnership Opportunities for the XXII World Allergy Congress.